Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is conducted in Asia. The aim of this observational study is to evaluate the weight change from baseline while using Levemir® in subjects with type 2 diabetes mellitus under normal clinical practice conditions in India.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin Detemir; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Any subject with type 2 diabetes

Exclusion Criteria:

• Subjects with a hypersensitivity to insulin detemir or any of its excipient

• Children below 6 years

• Subjects who are pregnant, lactating or planning to become pregnant